Browsing by Author Mak, SL

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 7 to 26 of 26 < previous 
TitleAuthor(s)Issue DateViews
 
Has-miR-141 plays a crucial role in ovarian cancer metastatic progression
Proceeding/Conference:HKU O & G 90th Anniversary Celebration Symposium
2015
77
 
Has-miR-141/KLF12/Survivin is a crtical pathway required for enhancing anoikis resistance of advanced ovarian cancer
Proceeding/Conference:CSHAsia 2015 Conference on Targeting Cell Death Mechanisms for the Treatment of Human Diseases
2015
89
 
2019
57
 
2017
30
 
2018
114
 
2017
133
miR-141 confers anoikis resistance of ovarian cancer cells by targeting KLF12
Proceeding/Conference:Annual Meeting of the American Association for Cancer Research, AACR 2012
2012
138
 
miR-141 confers anoikis resistance of ovarian cancer cells by targeting KLF12
Proceeding/Conference:Research Postgraduate Symposium, RPS 2012
2012
26
 
2014
73
 
2017
96
 
Role of Has-miR-141 as a therapeutic target and predictive biomarker for ovarian cancer
Proceeding/Conference:CSHAsia 2015 Conference on Precision Cancer Biology & Medicine
2015
95
 
2017
37
 
2012
50
 
The significance of lipid metabolism in peritoneal metastases of ovarian cancer
Proceeding/Conference:CSHAsia 2016 Conference on Cancer & Metabolism
2016
345
 
The upregulation of miR-141 confers anoikis resistance through targeting KLF12 in ovarian cancer cells
Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2012
2012
23
 
2011
85
 
The upregulation of miR-141 confers anoikis resistance through targeting KLF12 in ovarian cancer cells
Proceeding/Conference:9th Annual Conference on microRNA: Targets & Tools for Therapeutic Development
2013
45
 
2013
27
 
2016
45
 
2017
23